Government Doctors Are Not Allowed Private Practice: Health Ministry

NEW DELHI: As per Central Health Service (CHS) Rules, 2014, persons appointed to CHS shall not be allowed private practice of any kind whatsoever including any consultation and laboratory practice, according to the Ministry of Health. The ministry also informed the lower house today that doctors are entitled to a Non-Practicing Allowance (NPA) of 20% of Basic Pay subject to the condition that the Basic Pay plus NPA does not exceed Rs., 2,37,500/- after acceptance of the recommendations of the Seventh Central Pay Commission.

The Minister of State (Health and Family Welfare), Ashwini Kumar Choubey also stated in a written reply in the Lok Sabha here today that as and when any instance of private practice is brought to the notice of the Government, appropriate action is taken in the matter as per rules and procedure of the Government.

“As far as Central Government is concerned, as per Rule 13 of Central Health Service (CHS) Rules, 2014, persons appointed to CHS shall not be allowed private practice of any kind whatsoever including any consultation and laboratory practice,” the minister said.

“In lieu of private practice, doctors are entitled to a Non-Practicing Allowance (NPA) of 20% of Basic Pay subject to the condition that the Basic Pay plus NPA does not exceed Rs., 2,37,500/- after acceptance of the recommendations of the Seventh Central Pay Commission,” he added.

“Health being a State subject”, the minister also said, “no such information in respect of State Government Hospitals is maintained centrally”.

Related Posts

  • Health
  • July 18, 2025
  • 295 views
Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Prodigal ‘Surgeon’ Son returns from London to put Bihar on Robotic Surgery Map New Delhi: Bihar healthcare may be on the cusp of being cutting edge as prospect of its…

  • Pharma
  • July 16, 2025
  • 315 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates